Evidence map›Paper›PMID 33716763›Full record

ArticleFrontiers in physiology2021

Demonstration of Patient-Specific Simulations to Assess Left Atrial Appendage Thrombogenesis Risk.

Manuel García-Villalba, Lorenzo Rossini, Alejandro Gonzalo, Davis Vigneault, Pablo Martinez-Legazpi, Eduardo Durán, Oscar Flores, Javier Bermejo, Elliot McVeigh, Andrew M Kahn and 1 more

Open access · goldAbstract read
In one paragraph

Article in Frontiers in physiology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 43 papers.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed
12.6field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 102 citations in OpenAlex.

  1. Article
  2. Beyond CHAAnnals of biomedical engineering · 2026
    Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Observational
  9. Review
  10. Article
  11. Article
  12. Review
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 6 institutions in 2 countries.

Manuel García-VillalbaBioengineering and Aerospace Engineering Department, Carlos III University of Madrid, Leganés, Spain.
Lorenzo RossiniDepartment of Mechanical and Aerospace Engineering, University of California, San Diego, La Jolla, CA, United States.
Alejandro GonzaloDepartment of Mechanical and Aerospace Engineering, University of California, San Diego, La Jolla, CA, United States.
Davis VigneaultDepartment of Bioengineering, University of California, San Diego, La Jolla, CA, United States.
Pablo Martinez-LegazpiHospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio MaraMarañón, Facultad de Medicina, Universidad Complutense de Madrid, and CIBERCV, Madrid, Spain.
Eduardo DuránBioengineering and Aerospace Engineering Department, Carlos III University of Madrid, Leganés, Spain.
Oscar FloresBioengineering and Aerospace Engineering Department, Carlos III University of Madrid, Leganés, Spain.
Javier BermejoHospital General Universitario Gregorio Marañón, Instituto de Investigación Sanitaria Gregorio MaraMarañón, Facultad de Medicina, Universidad Complutense de Madrid, and CIBERCV, Madrid, Spain.
Elliot McVeighDepartment of Bioengineering, University of California, San Diego, La Jolla, CA, United States.
Andrew M KahnDivision of Cardiovascular Medicine, University of California, San Diego, La Jolla, CA, United States.
Juan C Del ÁlamoDepartment of Mechanical and Aerospace Engineering, University of California, San Diego, La Jolla, CA, United States.
University of California, San Diego · USUniversidad Carlos III de Madrid · ESCentro de Investigación en Red en Enfermedades Cardiovasculares · ESHospital General Universitario Gregorio Marañón · ESLa Jolla Bioengineering Institute · USUniversity of Washington · US

Funding

Hemodynamic Flow-Mediated Myocardial Reprogramming Impacts Cardiac DevelopmentR01HD092216 · NICHD · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHI, NEIL C · 2018 to 2022
$1.6M
NICHD NIH HHS R01 HD092216
6 · The paper itself

Abstract

Atrial fibrillation (AF) alters left atrial (LA) hemodynamics, which can lead to thrombosis in the left atrial appendage (LAA), systemic embolism and stroke. A personalized risk-stratification of AF patients for stroke would permit improved balancing of preventive anticoagulation therapies against bleeding risk. We investigated how LA anatomy and function impact LA and LAA hemodynamics, and explored whether patient-specific analysis by computational fluid dynamics (CFD) can predict the risk of LAA thrombosis. We analyzed 4D-CT acquisitions of LA wall motion with an in-house immersed-boundary CFD solver. We considered six patients with diverse atrial function, three with either a LAA thrombus (removed digitally before running the simulations) or a history of transient ischemic attacks (LAAT/TIA-pos), and three without a LAA thrombus or TIA (LAAT/TIA-neg). We found that blood inside the left atrial appendage of LAAT/TIA-pos patients had marked alterations in residence time and kinetic energy when compared with LAAT/TIA-neg patients. In addition, we showed how the LA conduit, reservoir and booster functions distinctly affect LA and LAA hemodynamics. Finally, fixed-wall and moving-wall simulations produced different LA hemodynamics and residence time predictions for each patient. Consequently, fixed-wall simulations risk-stratified our small cohort for LAA thrombosis worse than moving-wall simulations, particularly patients with intermediate LAA residence time. Overall, these results suggest that both wall kinetics and LAA morphology contribute to LAA blood stasis and thrombosis.

Indexed as

atrial fibrillationcardiovascular hemodynamicscomputational fluid dynamicscomputed tomographyimaged-based simulationimmersed boundary methodleft atriumthrombosis

Identifiers

PMID33716763
PMCPMC7953154
OpenAlexW3134754814

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.